I just see promotion here based on a "system and method" patent that looks dubious to me in terms of monetization. I would have to agree with that poster. I think I will pass, frankly I believe you have seen your run. Between those conversion shares and those who want to lock in their gains, when it turns it will likely turn hard. Just another view point to temper the emotional fervor. This is the OTC when it looks too good to be true you can bet your losses that it is. :-D